Performance of the new INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens

Acta Cytologica

Volumn 55, Issue 4, 2011, Pages 341-343

  Galan Sanchez, Fátima ^a   Hernández Menendez, Maite ^a   De Los Rios Hernandez, María Angeles ^a   Rodriguez Iglesias, Manuel ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Human papillomavirus; Human papillomavirus genotyping; INNO LiPA Extra; Linear arrays; Reverse hybridization

Indexed keywords

ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CYTOLOGY; WART VIRUS; COMPARATIVE STUDY; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR DIAGNOSIS; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

VIRUS DNA;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80052880740     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000327526     Document Type: Article

References (15)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
2. van Hamont D, Bekkers RL, Massuger LF, Melchers WJ: Detection, management, and follow-up of pre-malignant cervical lesions and the role for human papillomavirus. Rev Med Virol 2008; 18: 117-132.
3. Meijer CJ, Snijders PJ, Castle PE: Clinical utility of HPV genotyping. Gynecol Oncol 2006; 103: 12-17.
4. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517.
5. van Doorn LJ, Quint W, Kleter B, Molijn A, Colau B, Martin MT, et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 2002; 40: 979-983.
6. Sabol I, Salakova M, Smahelova J, Pawlita M, Schmitt M, Gasperov NM, et al. Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol 2008; 46: 1606-1613.
7. Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 2008; 80: 1264-1274.
8. Fontaine V, Mascaux C, Weyn C, Bernis A, Celio N, Lefevre P, et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol 2007; 45: 928-934.
9. van Hamont D, van Ham MA, Bakkers JM, Massuger LF, Melchers WJ: Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 2006; 44: 3122-3129.
10. Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Zerat L, et al. Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. Sex Transm Dis 2008; 35: 521-527.
11. Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, et al: Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear. Int J STD AIDS 2008; 19: 385-392.
12. Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C: Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions. J Clin Virol 2009; 45(suppl 1):S55-S61.
13. Poljak M, Marin IJ, Seme K, Vince A: Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 2002; 25(suppl 3):S89-S97.
14. Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, et al. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5683 young women in Guanacaste, Costa Rica. J Clin Microbiol 2007; 45: 1447-1454.
15. Maver PJ, Kocjan BJ, Seme K, Potocnik M, Gale N, Poljak M: Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 fulllength genome sequences. J Med Virol 2011; 83: 461-470.